Remed issues ₩10.0bn convertible bonds maturing Nov 4, 2031

Remed · KOSDAQ · 302550 · Oct 14, 2026 · Convertible bonds

Remed filed for ₩10.0bn in convertible bonds with a 1.0% coupon, maturing Nov 4, 2031. The conversion price is ₩2,774, and conversion could issue 3,604,902 shares, or 11.9% of total shares. The face amount is 40.8% of FY2025 revenue by our calculation.

Key facts

Face amount₩10.0bn
Conversion price₩2,774
Shares issuable on conversion3,604,902 shares
% of total shares11.9%
Maturity dateNov 4, 2031
Coupon rate1.0%

Comparison

Amount as % of FY2025 revenue (calculated)40.8%
Revenue 2025₩24.5bn
Revenue 2024₩25.6bn
Revenue 2023₩18.5bn

Context

In the 12 months before this filing, insiders made net open-market purchases of 12,000 shares.

Key metrics

Potential dilution

CB/BW/EB issued, last 12 months₩10.0bn As of Oct 14, 2026 Source 1
Rights offering new shares, last 12 months0 shares As of Nov 19, 2026
Potential new shares, last 12 months3,604,902 shares As of Oct 14, 2026 Source 1
Potential new shares, % of shares11.9% As of Oct 14, 2026 Source 1, Source 2 ↗
Conversion price adjustments, last 12 months0 As of Nov 19, 2026

Source: DART (Financial Supervisory Service) · Original filing on DART ↗ (opens the Financial Supervisory Service's DART site)